CanSino Biologics
(OTC) CASBF
CanSino Biologics Financials at a Glance
Market Cap
$953.59M
Revenue (TTM)
$1.06B
Net Income (TTM)
$27.66M
EPS (TTM)
$0.02
P/E Ratio
242.77
Dividend
$0.00
Beta (Volatility)
-0.11 (Low)
Dividend
$0.00
Beta (Volatility)
-0.11 (Low)
Price
$3.86
Volume
50
Open
$3.86
Price
$3.86
Volume
50
Open
$3.86
Previous Close
$3.86
Daily Range
$3.86 - $3.86
52-Week Range
$3.20 - $6.99
Dividend
$0.00
Beta (Volatility)
-0.11 (Low)
Price
$3.86
Volume
50
Open
$3.86
Previous Close
$3.86
Daily Range
$3.86 - $3.86
52-Week Range
$3.20 - $6.99
CASBF News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout CanSino Biologics
Industry
Biotechnology
Sector
Health CareEmployees
1,134
CEO
Xue Feng Yu, PhD
Website
www.cansinotech.comHeadquarters
Tianjin, CN
CASBF Financials
Key Financial Metrics (TTM)
Gross Margin
100%
Operating Margin
2%
Net Income Margin
3%
Return on Equity
57%
Return on Capital
0%
Return on Assets
0%
Earnings Yield
0.41%
Dividend Yield
0.00%
Payout Ratio
1.31%
Stock Overview
Market Cap
$953.59M
Shares Outstanding
247.04M
Volume
50
Short Interest
0.00%
Avg. Volume
34.774
Financials (TTM)
Gross Profit
$681.87M
Operating Income
$113.13M
EBITDA
$60.98M
Operating Cash Flow
$32.49M
Capital Expenditure
$185.33M
Free Cash Flow
$152.84M
Cash & ST Invst.
$2.65B
Total Debt
$1.29B
CanSino Biologics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$369.83M
+32.4%
Gross Profit
$240.28M
+47.6%
Gross Margin
64.97%
N/A
Market Cap
$953.59M
N/A
Market Cap/Employee
$862.98K
N/A
Employees
1,105
N/A
Net Income
$13.24M
+108.5%
EBITDA
$19.14M
+110.9%
Quarterly Fundamentals
Net Cash
$1.36B
+13.8%
Accounts Receivable
$793.09M
+7.5%
Inventory
$348.02M
+22.8%
Long Term Debt
$965.05M
-13.2%
Short Term Debt
$323.25M
-64.1%
Return on Assets
0.39%
N/A
Return on Invested Capital
0.39%
N/A
Free Cash Flow
$8.06M
+170.2%
Operating Cash Flow
$73.06M
-39.2%